Pasithea Therapeutics Valuation
| KTTAW Stock | USD 0.02 0.00 0.00% |
Pasithea Therapeutics seems to be fairly valued based on Macroaxis valuation methodology. Our model determines the value of Pasithea Therapeutics from analyzing the company fundamentals such as Revenue of 486.56 K, net income of (15.51 M), and Return On Equity of -0.63 as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Pasithea Therapeutics' price fluctuation is out of control at this time. Calculation of the real value of Pasithea Therapeutics is based on 3 months time horizon. Increasing Pasithea Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Pasithea stock is determined by what a typical buyer is willing to pay for full or partial control of Pasithea Therapeutics Corp. Since Pasithea Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Pasithea Stock. However, Pasithea Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0201 | Real 0.02 | Hype 0.0233 | Naive 0.0303 |
The intrinsic value of Pasithea Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Pasithea Therapeutics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Pasithea Therapeutics Corp helps investors to forecast how Pasithea stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Pasithea Therapeutics more accurately as focusing exclusively on Pasithea Therapeutics' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Pasithea Therapeutics' intrinsic value based on its ongoing forecasts of Pasithea Therapeutics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Pasithea Therapeutics' closest peers.
Pasithea Therapeutics Cash |
|
Pasithea Valuation Trend
Analysing the historical paterns of Pasithea Therapeutics' enterprise value and its market capitalization is a good way to estimate and gauge the value of Pasithea Therapeutics Corp over time and is usually enough for investors to make rational market timing decisions.
Pasithea Therapeutics Total Value Analysis
Pasithea Therapeutics Corp is now forecasted to have takeover price of 0 with market capitalization of 0, debt of 81.68 K, and cash on hands of 568.98 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Pasithea Therapeutics fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
0 | 0 | 81.68 K | 568.98 K |
Pasithea Therapeutics Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Pasithea Therapeutics has an asset utilization ratio of 1.86 percent. This indicates that the Company is making $0.0186 for each dollar of assets. An increasing asset utilization means that Pasithea Therapeutics Corp is more efficient with each dollar of assets it utilizes for everyday operations.Pasithea Therapeutics Profitability Analysis
The company reported the revenue of 486.56 K. Net Loss for the year was (15.51 M) with profit before overhead, payroll, taxes, and interest of 0.About Pasithea Therapeutics Valuation
Our relative valuation model uses a comparative analysis of Pasithea Therapeutics. We calculate exposure to Pasithea Therapeutics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Pasithea Therapeutics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -648.5 K | -616 K | |
| Pretax Profit Margin | (25.78) | (27.07) | |
| Operating Profit Margin | (27.41) | (28.78) | |
| Net Loss | (24.15) | (25.36) | |
| Gross Profit Margin | 0.69 | 0.73 |
Pasithea Therapeutics Growth Indicators
Investing in growth stocks can be very risky. If the company such as Pasithea Therapeutics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 1.2 M |
Pasithea Therapeutics Current Valuation Indicators
Valuation refers to the process of determining the present value of Pasithea Therapeutics Corp and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Pasithea we look at many different elements of the entity such as Pasithea's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Pasithea Therapeutics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Pasithea Therapeutics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Pasithea Therapeutics' worth.Additional Tools for Pasithea Stock Analysis
When running Pasithea Therapeutics' price analysis, check to measure Pasithea Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pasithea Therapeutics is operating at the current time. Most of Pasithea Therapeutics' value examination focuses on studying past and present price action to predict the probability of Pasithea Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pasithea Therapeutics' price. Additionally, you may evaluate how the addition of Pasithea Therapeutics to your portfolios can decrease your overall portfolio volatility.